In a recent move, Samsung Medison builds new manufacturingย facility forย diagnostic ultrasound equipment inย Hongcheon, South Korea.
The new site forms part of the Samsung Electronics subsidiary’s $37.4 million capital investment to increase its production capacity and improve manufacturing procedures to satisfy the requirements of the global medical device market, saidย the company. Interestingly, the new facility marks the biggest production growth since it joined Samsung in 2011.
Notably, Samsung Medison will manufacture its premium ultrasound devices, including the Samsung R20 as well as Hera Z20, at the Hongcheon plant. Samsung Medison aims to boost its annual output capacity to 40,000 units from 24,000 units by the end of the decadeย and establish itself as a critical global supply hub.
All production will be done in-house, including the manufacturing ofย circuit boards,ย mechanical assembling, dependability evaluation using high-temperature aging, and shipping of finished products, the company said.
The new manufacturing plant creates not only a full in-house production process but also more automated equipment and intelligent procedures in the production lines, which are designed for particular features and logistics of the products.
The simplified process also guarantees that each product is fully inspected at every level of manufacturing.
Samsung Medison Manufacturing lead, Son Hyun-soo, said to The Korea Herald that the [surface-mount device] line used to be semi-automated, but weโve introduced new automated equipment with this expansion. Weโve also replaced what used to be basic finished-product testing with an automated system.โ
Samsung Medison introduced Samsungโs global supply chain management infrastructure into the new facility to improve its capacity to manufacture key components internally and to enhance supply stability while flexibly adapting to fluctuations in supply and demand of components.
As Samsung Medison builds new manufacturingย facility, it is indeed a watershed moment that goes beyond the growth of production facilities in order to boost the manufacturing competitiveness of Samsung Medisonย in the global medical device market to the next level, said theย CEO of Samsung Medison and head of Samsung Electronicsโ medical devices business, Yoo Kyu-tae, in anย announcement.
He added, โWe will continue to lead technological innovation that spearheads the global medical device market while contributing to medical professionals and patients worldwide through uncompromising quality and stable equipment supply.”

